133 related articles for article (PubMed ID: 2485134)
1. Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts.
Bak M; Mattern J; Volm M
In Vivo; 1987; 1(5):319-26. PubMed ID: 2485134
[TBL] [Abstract][Full Text] [Related]
2. [Morphologic and tumor-marker studies of human planocellular carcinoma of the bronchi in xenografts].
Bak M; Mattern J; Volm M
Morphol Igazsagugyi Orv Sz; 1989 Apr; 29(2):81-8. PubMed ID: 2747666
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
4. Comparative histopathology of human epidermoid lung carcinoma xenografts.
Bak M; Mattern J; Volm M
Strahlenther Onkol; 1989 Jul; 165(7):485-6. PubMed ID: 2749470
[No Abstract] [Full Text] [Related]
5. Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.
Volm M; Bak M; Efferth T; Lathan B; Mattern J
Anticancer Res; 1988; 8(4):531-5. PubMed ID: 2902821
[TBL] [Abstract][Full Text] [Related]
6. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
7. B-cell antigen marker expression in nasopharyngeal carcinoma.
Zhong XY; Senba M; Gu JN; Itakura H
Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma.
Miettinen M
Arch Pathol Lab Med; 1988 Jun; 112(6):637-40. PubMed ID: 2454091
[TBL] [Abstract][Full Text] [Related]
10. Trophoblastic markers and CEA in non-small cell lung cancer: the comparison studies of tumour cells expression and serum concentration.
Słodkowska J; Szturmowicz M; Giedronowicz D; Rudzinski P; Sakowicz A; Kupis W
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():190-8. PubMed ID: 9337537
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic and acquired multidrug resistance in human lung carcinomas grown in nude mice.
Mattern J; Bak M; Volm M
Anticancer Res; 1990; 10(1):177-80. PubMed ID: 1970715
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
Kamel OW; Rouse RV; Warnke RA
Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
[TBL] [Abstract][Full Text] [Related]
13. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
14. [Epithelial markers of 2 cytokeratin-negative small cell bronchial cancers].
Bohrer MH; Hastka J
Pathologe; 1991 Jan; 12(1):21-3. PubMed ID: 1708881
[No Abstract] [Full Text] [Related]
15. Giant cell carcinoma of the lung--immunohistochemical and ultrastructural evidence of dedifferentiation.
Addis BJ; Dewar A; Thurlow NP
J Pathol; 1988 Jul; 155(3):231-40. PubMed ID: 2457672
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary adenosquamous carcinomas with amyloid-like stroma.
Yousem SA
Mod Pathol; 1989 Sep; 2(5):420-6. PubMed ID: 2479006
[TBL] [Abstract][Full Text] [Related]
17. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue.
Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR
J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037
[TBL] [Abstract][Full Text] [Related]
19. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
20. Tumor marker studies of cervical smears: an immunohistochemical approach.
Sarker AB; Koirala TR; Nose S; Jeon HJ; Hoshida Y
Indian J Pathol Microbiol; 1994 Jan; 37(1):45-51. PubMed ID: 7522221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
